Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

PSPs

Impetus Digital Fireside Chat With Richie Bavasso From NqMedical

Richie Bavasso, founder and CEO of nQMedical, discusses everything from digital therapeutics, diagnostics, and other data-driven solutions for neurodegenerative diseases to Richie’s favorite media outlets, his work at nQMedical, and lessons learned...

Impetus Digital

- PMLiVE

Making a difference with patient support

A clear understanding of the patient journey and experience is pivotal in designing patient support programmes

Bedrock Healthcare Communications

Digital Nation: How Australia became a digital health pioneer

Australia has adopted digital strategies to transform its healthcare system. We sat down with Rachel de Sain, who shares where, and how she contributed to improving digital health products and...

Blue Latitude Health

- PMLiVE

Half of European cancer drug trials ‘biased’, says BMJ

Report says studies exaggerate benefits

Battling breast cancer with precision medicine (Part 1)

Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate...

Blue Latitude Health

- PMLiVE

Hesperos’ ‘human-on-a-chip’ predicts drug toxicity in the lab

Drug discovery potential

- PMLiVE

Merck & Co picks Nike exec to be digital transformation leader

Cyber-security and customer focus will be key issues

Digital Pharma Advances London 2018

Digital Pharma Advances 2018: Attend our presentation in London

We are very excited to be attending and speaking at The Digital Pharma Advances Conference, held January 30th in London.

Anthill Agency

- PMLiVE

Victoza cuts cardiovascular risk in landmark study

Novo Nordisk’s diabetes therapy outcomes ‘beyond expectations’

AstraZeneca AZ global R&D corporate HQ

AZ’s tremelimumab fails mesothelioma trial

FDA-designated breakthrough therapy did not demonstrate increase in overall survival

- PMLiVE

US proposes tighter rules on clinical trial reporting

If approved, data from around 650 additional studies per year will be released

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links